Mei Sun

Title: **Inventor Mei Sun and His Contributions to Mucolipidosis Research**

Introduction

Mei Sun, an accomplished inventor based in Rockville, MD, has made significant strides in the field of genetic research, particularly concerning mucolipidosis IV. With a patent under his name, he is known for his work in identifying a gene that plays a crucial role in this condition.

Latest Patents

Mei Sun holds a notable patent titled "Gene encoding a new TRP channel is mutated in mucolipidosis IV." This invention involves the identification of a gene that is inactivated in mucolipidosis, specifically the mutations that disrupt the mucolipin MCOLN1 in mucolipidosis IV. His patent also encompasses recombinant nucleic acids encoding these mutant forms of MCOLN1, specific oligonucleotides for such mutations, along with diagnostic and therapeutic applications related to these findings.

Career Highlights

Throughout his career, Mei Sun has worked with reputable organizations, including the ML4 Foundation and The General Hospital Corporation. His endeavors in these institutions have contributed to advancing the understanding and treatment of mucolipidosis and related genetic disorders.

Collaborations

Mei Sun has collaborated with esteemed colleagues such as Ehud Goldin and Susan A. Slaugenhaupt. These collaborations have aided in enriching research efforts directed at exploring genetic conditions and developing innovative solutions for affected individuals.

Conclusion

Mei Sun's contributions as an inventor and researcher exemplify the impactful role that innovations in genetics can play in addressing complex health issues such as mucolipidosis IV. Through his patented work and collaborations, he continues to push the boundaries of knowledge and technology in the medical field.